Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.
Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T.
Mult Scler. 2022 Nov 30. 13524585221137697. PMID: 36448331